Compare uniQure N.V. Ordinary Shares (QURE) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Veritone Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $21.88 (market cap $1.45B), while Veritone Inc trades at $0.52 (market cap $53.70M). The key difference: uniQure N.V. Ordinary Shares is far larger — about 27× Veritone Inc's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Veritone Inc for 13 Days on average.
| QURE | VERI | |
|---|---|---|
Market Cap | $1.45B | $53.70M |
Volume | 3,323,243 | 4,439,104 |
Sector | Health | Technology |
52-Week High | $70.59 | $8.39 |
52-Week Low | $9.03 | $0.53 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $707.46M | $89.09M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Veritone (VERI) trades at $0.59, down 2.64% today, with a bearish technical outlook despite oversold RSI readings. The company shows significant financial challenges with a -117.54% net income margin and consistent quarterly losses, though it maintains a reasonable P/S ratio of 0.5. Recent developments include a $15 million equity offering and new partnerships with ATP Media and ZeroEyes, while facing securities class action litigation.
The stock presents high risk with substantial losses and negative cash flow from operations, though analyst consensus suggests potential upside to $3.75. Investment opportunity exists only for speculative investors betting on AI growth potential, with significant execution and litigation risks weighing on near-term prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
